StephenJamesRushMD

Gay, Lesbian, Transgender Focused, Neuropsychiatry, Psychopharmacology

Associate Professor of Clinical Psychiatry

Dr. Rush is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Dr. Stephen Rush is a psychiatrist in Cincinnati, OH and is affiliated with University of Cincinnati Medical Center. He received his medical degree from Indiana University School of Medicine and has been in practice 10 years. He specializes in gay, lesbian, and transgender health, neuropsychiatry (including autoimmune encephalitis), and psychopharmacology. He is experienced in the psychiatric manifestations of autoimmune encephalitis, treatment refractory illnesses including bipolar disorder, schizophrenia, depression, and posttraumatic stress disorder as well as psychodynamic psychotherapy. He is also involved in the treatment of refractory depression with transcranial magentic stimulation (TMS) and ketamine. He has served as the medical director of ambulatory services for the Department of Psychiatry at the University of Cincinnati Medical Center since 2019 and is a board member of the CureSz organization.

University of Cincinnati Medical Center/College of MedicineResidency, Psychiatry, 2009 - 2013
Indiana University School of MedicineClass of 2009
Indiana UniversityB.S., Biology, Minor: French, Degree of Distinction for Academic Performance, 1998 - 2003

Top Doctors Cincinnati Magazine, 2021
Top Provider in Patient Experience University of Cincinnati College of Medicine, 2019
Medical Student Teaching Award-Inpatient Psychiatry University of Cincinnati Department of Psychiatry and Behavioral Neuroscience, 2017
Golden Apple Award General Psychiatry Residency Clinical Education, University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience, 2017
Golden Apple Teaching Award University of Cincinnati Department of Psychiatry and Behavioral Neuroscience, 2015
Golden Apple Award University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience, 2013
The Maurice and Diane Levine APA Travel Award 2013
Phi Beta Kappa Indiana University, 2003
Join now to see all

PubMed

32 citations
c-jun amino-terminal kinase and mitogen activated protein kinase 1/2 mediate hepatocyte growth factor-induced migration of brain endothelial cells.
Stephen Rush, Gausal A. Khan, Ayoola Bamisaiye, Philip Bidwell, H. Anne Leaver, Maria Teresa Rizzo> ;Experimental Cell Research. 2007 Jan 1

Journal Articles

Abstracts/Posters

Neurotoxic Effects of the Older Antipsychotics: Several Molecular Mechanisms of Action.
Rush, S and Nasrallah, N., Annual meeting of the American Psychiatric Association, San Francisco, CA., 5/1/2013
Constitutive expression of the microsomal prostaglandin E synthase regulates glioma cell growth via the production of prostaglandin E2
Rizzo MT, Knapp B and Rush S, Prostaglandins and Other Lipid Mediators, 3/2006
Neurotoxic Effects of the Older Antipsychotics: Several Molecular Mechanisms of Action
Rush, SJ and Nasrallah, NA, American Psychiatric Association, San Francisco, CA

Lectures

Crossroads: Autoimmune Encephalitis and Psychiatry
Euroimmun Neuroimmunology Summit - 6/15/2020
Secondary Psychosis: Differential Diagnosis of a First Episode
College of Psychiatric and Neurologic Pharmacists Annual Meeting - 4/15/2020
Autoimmune Encephalitis: The Crossroads of Neurology and Psychiatry
University of Cincinnati Medical Center/Autoimmune Encephalitis Alliance - 8/17/2019
Key Note Speaker: Transcranial Magnetic Stimulation
41st Annual Cleveland Consult-Liason Society Meeting - 5/23/2019
Neuromodulation and Depression
6th Annual Mood Disorders Symposium University of Cincinnati - 4/16/2016
Join now to see all

Constitutive expression of the microsomal prostaglandin E synthase regulates glioma cell growth via the production of prostaglandin E2January 2007

Catatonic Schizophrenia: How to Recognize the Symptoms of a Catatonic StateJuly 17th, 2019
Computer-Assisted Cognitive Remediation for SchizophreniaMay 13th, 2019
Magnetic Force: How TMS Therapy for Depression Got Patient Back on StageJune 7th, 2018

Sub-investigator“A Study to Compare Disease Progression and Modification Following Treatment with Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform (DREaM).” Janssen Pharmaceuticals. UC Department of Psychiatry2015 - 2018